<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>10</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vanessa Mathys</style></author><author><style face="normal" font="default" size="100%">Karine Soetaert</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Tuberculose en antibioticaresistentie: het WIV draagt bij tot de ontwikkeling van een nieuw prototype van een geneesmiddel</style></title><secondary-title><style face="normal" font="default" size="100%">WIV-ISP website</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">antibioresistentie</style></keyword><keyword><style  face="normal" font="default" size="100%">geneesmiddelen</style></keyword><keyword><style  face="normal" font="default" size="100%">tuberculose</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">20/03/2017</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.wiv-isp.be/nl/pershoek/tuberculose-en-antibioticaresistentie-het-wiv-draagt-bij-tot-de-ontwikkeling-van-een-nieuw</style></url></web-urls></urls><publisher><style face="normal" font="default" size="100%">WIV-ISP</style></publisher><pub-location><style face="normal" font="default" size="100%">Brussels, Belgium</style></pub-location><pages><style face="normal" font="default" size="100%">1</style></pages></record></records></xml>